BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26947496)

  • 1. Quality vaccines for all people: Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05-07th October 2015, Bangkok, Thailand.
    Pagliusi S; Ting CC; Khomvilai S;
    Vaccine; 2016 Jun; 34(31):3562-7. PubMed ID: 26947496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.
    Pagliusi S; Makhoana M; Datla M; Leite L; Hendriks J; Gholami A; Huang W; Gao Y; Jadhav S; Harshavardhan GV; Wu Y; Suhardono M; Homma A
    Vaccine; 2013 Jun; 31(31):3111-5. PubMed ID: 23684836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines: Shaping global health.
    Pagliusi S; Ting CC; Lobos F;
    Vaccine; 2017 Mar; 35(12):1579-1585. PubMed ID: 28237501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The art of partnerships for vaccines.
    Pagliusi S; Che Y; Dong S
    Vaccine; 2019 Sep; 37(40):5909-5919. PubMed ID: 31447125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines, inspiring innovation in health.
    Pagliusi S; Dennehy M; Kim H;
    Vaccine; 2018 Nov; 36(48):7430-7437. PubMed ID: 29789241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better vaccines for healthier life. Part I. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam.
    Pagliusi S; Rustan R; Huang W; Nguyen T;
    Vaccine; 2014 Nov; 32(48):6325-9. PubMed ID: 24923636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines, our shared responsibility.
    Pagliusi S; Jain R; Suri RK;
    Vaccine; 2015 May; 33(19):2197-2202. PubMed ID: 25749248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.
    Pagliusi S; Leite LC; Datla M; Makhoana M; Gao Y; Suhardono M; Jadhav S; Harshavardhan GV; Homma A
    Vaccine; 2013 Apr; 31 Suppl 2():B176-83. PubMed ID: 23598479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
    Jadhav S; Datla M; Kreeftenberg H; Hendriks J
    Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
    Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
    Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
    Pagliusi S; Hayman B; Jarrett S
    Vaccine; 2021 Apr; 39(18):2479-2488. PubMed ID: 33838948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better vaccines for healthier life. Part II. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam.
    Pagliusi S; Tippoo P; Sivaramakrishnan V; Nguyen T;
    Vaccine; 2014 Nov; 32(48):6330-5. PubMed ID: 24923638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status.
    Jadhav SS; Gautam M; Gairola S
    Biologicals; 2009 Jun; 37(3):165-8. PubMed ID: 19328010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil.
    Pagliusi S; Dennehy M; Homma A
    Vaccine; 2020 Aug; 38(36):5851-5860. PubMed ID: 32535016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices.
    Jadhav S; Gautam M; Gairola S
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():37-44. PubMed ID: 24476201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging vaccine manufacturers are innovating for the next decade.
    Hayman B; Pagliusi S
    Vaccine X; 2020 Aug; 5():100066. PubMed ID: 32462140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinology capacity building in Europe for innovative platforms serving emerging markets.
    Hendriks J; Holleman M; Hamidi A; Beurret M; Boog C
    Hum Vaccin Immunother; 2013 Apr; 9(4):932-6. PubMed ID: 23563518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Workshops advocating ASEAN Vaccine Security and Self-Reliance (AVSSR): A regional initiative.
    Muangchana C; Thanormwat Y; Kongsiang A
    Vaccine; 2019 Mar; 37(14):2034-2041. PubMed ID: 30033115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunization in developing countries: practical and theoretical problems and prospects.
    Arya SC
    Vaccine; 1994 Nov; 12(15):1423-35. PubMed ID: 7887021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Children's Vaccine Initiative and vaccine supply: the role of the public sector.
    van Noort RB
    Vaccine; 1992; 10(13):909-10. PubMed ID: 1471410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.